RESET

Dreaming of no more renal dialysis: how self-derived tissue and cells can replace renal function

 Coordinatore ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Italy [IT]
 Totale costo 2˙493˙000 €
 EC contributo 2˙493˙000 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2010-AdG_20100317
 Funding Scheme ERC-AG
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-05-01   -   2016-04-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

 Organization address address: Via Giuseppe La Masa 19
city: MILANO
postcode: 20156

contact info
Titolo: Ms.
Nome: Maria Grazia
Cognome: Pezzoni
Email: send email
Telefono: +39 02 39014304
Fax: +39 02 39009728

IT (MILANO) hostInstitution 2˙493˙000.00
2    ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

 Organization address address: Via Giuseppe La Masa 19
city: MILANO
postcode: 20156

contact info
Titolo: Prof.
Nome: Giuseppe
Cognome: Remuzzi
Email: send email
Telefono: +39 035 4213401
Fax: +39 035 319331

IT (MILANO) hostInstitution 2˙493˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

cells    dialysis    strategy    pluripotent    reprogramming    cellularization    patient    transplantation    organ    ips    de    ckd    status    human    kidneys    transplanted    intact    vivo    rodent    chronic    kidney    scaffold   

 Obiettivo del progetto (Objective)

'For chronic kidney diseases there is little chance that the vast majority of the world¿s population will have access to renal replacement therapy with dialysis. There is yet no adequate alternative with curative intent than allo-transplantation. This approach is seriously impaired by eventually limited graft survival and by the scarce availability of donors. We propose an innovative strategy that would help to simultaneously overwhelm the reduced access to dialysis, the need for organs for transplantation, the avoidance of patient exposure to immunosuppressants. The overall focus is based on the idea of generating new kidneys by tissue engineering technologies starting from a whole-kidney scaffold with intact three-dimensional geometry and vasculature created by de-cellularization of a kidney harvested from the patient with progressive chronic kidney disease (CKD). Repopulation of the kidney scaffold could be achieved with patient-specific induced pluripotent stem (iPS) cells generated by reprogramming to a pluripotent status of somatic cells. After regeneration, the kidney will be transplanted in the same patient. Thereafter, the same procedures will be repeated with the contralateral native injured kidney, after in vivo assessment of the proper functional performance of the newly generated transplanted organ. This goal will be pursued through the three steps introductory to the development of the best strategy for translating the proposed frontier research to patients with CKD: 1.Create an intact whole-kidney scaffold by de-cellularization of a rodent kidney and validate the procedure with a human kidney. 2. Attempt to reconstruct the organ by reseeding the rodent and human whole-kidney scaffolds with iPS cells generated by reprogramming adult dermal fibroblasts to a pluripotent status. 3. Deeply characterize the function of the new rodent and human kidneys by in vivo and in vitro techniques.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

KIDNEY CANCER (2010)

Molecular mechanisms underlying control of renal epithelial proliferative homeostasis

Read More  

BETAREGENERATION (2012)

Induction of Insulin-producing beta-cells Regeneration in vivo

Read More  

LOWCOSTPEROXIDE (2013)

Novel low cost catalyst for direct hydrogen peroxide synthesis

Read More